Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis

PA Lyons, EF McKinney, TF Rayner, A Hatton… - Annals of the …, 2010 - ard.bmj.com
PA Lyons, EF McKinney, TF Rayner, A Hatton, HB Woffendin, M Koukoulaki, TC Freeman…
Annals of the rheumatic diseases, 2010ard.bmj.com
Objective To optimise a strategy for identifying gene expression signatures differentiating
systemic lupus erythematosus (SLE) and antineutrophil cytoplasmic antibody-associated
vasculitis that provide insight into disease pathogenesis and identify biomarkers. Methods
44 vasculitis patients, 13 SLE patients and 25 age and sex-matched controls were enrolled.
CD4 and CD8 T cells, B cells, monocytes and neutrophils were isolated from each patient
and, together with unseparated peripheral blood mononuclear cells (PBMC), were …
Objective
To optimise a strategy for identifying gene expression signatures differentiating systemic lupus erythematosus (SLE) and antineutrophil cytoplasmic antibody-associated vasculitis that provide insight into disease pathogenesis and identify biomarkers.
Methods
44 vasculitis patients, 13 SLE patients and 25 age and sex-matched controls were enrolled. CD4 and CD8 T cells, B cells, monocytes and neutrophils were isolated from each patient and, together with unseparated peripheral blood mononuclear cells (PBMC), were hybridised to spotted oligonucleotide microarrays.
Results
Using expression data obtained from purified cells a substantial number of differentially expressed genes were identified that were not detectable in the analysis of PBMC. Analysis of purified T cells identified a SLE-associated, CD4 T-cell signature consistent with type 1 interferon signalling driving the generation and survival of tissue homing T cells and thereby contributing to disease pathogenesis. Moreover, hierarchical clustering using expression data from purified monocytes provided significantly improved discrimination between the patient groups than that obtained using PBMC data, presumably because the differentially expressed genes reflect genuine differences in processes underlying disease pathogenesis.
Conclusion
Analysis of leucocyte subsets enabled the identification of gene signatures of both pathogenic relevance and with better disease discrimination than those identified in PBMC. This approach thus provides substantial advantages in the search for diagnostic and prognostic biomarkers in autoimmune disease.
ard.bmj.com